
Parkinson's disease results from neuron loss, which affects millions worldwide.
Transplantation of fetal tissue to restore this loss has shown promise, but ethical concerns over acquiring this tissue limit its use.
Advertisement
In a June 17 study in the Journal of Clinical Investigation, Vania Broccoli and others at the San Raffaele Scientific Institute converted fibroblasts into neurons and engrafted them into the brains of rodents with parkinsonism.
The cells improved motor function, but not as well as transplanted rat fetal tissues. The authors then used a technology that allows the neurons to express engineered proteins, which respond to a specific drug to regulate neuronal activity.
These neurons restored motor function almost as well as rat fetal tissue. An accompanying article discusses how this study potentially provides a promising source of replacement neurons in Parkinson's disease.
Source: Eurekalert
These neurons restored motor function almost as well as rat fetal tissue. An accompanying article discusses how this study potentially provides a promising source of replacement neurons in Parkinson's disease.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News

Tobacco smoke contains toxic chemicals which damage lungs, weaken the immune system and cause tuberculosis.

Identifying an unappreciated relationship between brain shape and activity overturns the century-old paradigm emphasizing the importance of complex brain connectivity.

Decoding the eight factors affecting Black adults' life expectancy.

Sobering truth about foot travel in the United States emerges from international statistics, highlighting the prevalence of walking on the Blacksburg campus.

Unveiling a hidden mechanism, proteins within brain cells exhibit newfound abilities at synapses, reinforcing Darwin's theory of adaptation and diversity in the natural world.